Total Payments
$142,628
2024 Payments
$21,488
Companies
44
Transactions
1,640
Medicare Patients
20,906
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$91,118 (63.9%)
Food & Beverage$33,359 (23.4%)
Consulting$9,645 (6.8%)
Travel$7,451 (5.2%)
Education$950.44 (0.7%)
Research$104.58 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91,118 | 43 | 63.9% |
| Food and Beverage | $33,359 | 1,536 | 23.4% |
| Consulting Fee | $9,645 | 5 | 6.8% |
| Travel and Lodging | $7,451 | 42 | 5.2% |
| Education | $950.44 | 13 | 0.7% |
| Unspecified | $104.58 | 1 | 0.1% |
Payments by Type
General
$142,523
1,639 transactions
Research
$104.58
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $42,887 | 144 | $0 (2024) |
| ABBVIE INC. | $31,777 | 355 | $0 (2024) |
| PFIZER INC. | $24,258 | 150 | $0 (2024) |
| Dermavant Sciences, Inc. | $13,002 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,508 | 146 | $0 (2024) |
| Eli Lilly and Company | $3,426 | 7 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $3,372 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $2,754 | 139 | $0 (2024) |
| LEO Pharma Inc. | $2,604 | 74 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,727 | 89 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,488 | 281 | ABBVIE INC. ($14,394) |
| 2023 | $30,031 | 288 | Lilly USA, LLC ($15,567) |
| 2022 | $46,130 | 280 | Lilly USA, LLC ($13,427) |
| 2021 | $18,027 | 224 | Lilly USA, LLC ($10,872) |
| 2020 | $7,818 | 100 | PFIZER INC. ($5,980) |
| 2019 | $13,769 | 194 | PFIZER INC. ($6,659) |
| 2018 | $3,247 | 152 | AbbVie, Inc. ($764.91) |
| 2017 | $2,119 | 121 | AbbVie, Inc. ($492.95) |
All Payment Transactions
1,640 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: DERMATOLOGY | ||||||
| 12/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Immunology | ||||||
| 12/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $121.40 | General |
| Category: Immunology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Immunology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $39.70 | General |
| Category: Immunology | ||||||
| 11/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $43.57 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $130.82 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $104.58 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 7,129 | 11,392 | $1.4M | $551,774 |
| 2022 | 30 | 4,865 | 7,340 | $955,998 | $377,346 |
| 2021 | 30 | 4,968 | 7,261 | $944,568 | $377,234 |
| 2020 | 26 | 3,944 | 5,616 | $702,390 | $277,339 |
Total Patients
20,906
Total Services
31,609
Medicare Billing
$1.6M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,953 | 3,062 | $364,378 | $190,444 | 52.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 768 | 897 | $139,035 | $59,159 | 42.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,074 | 1,416 | $220,896 | $56,140 | 25.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 759 | 759 | $117,645 | $55,160 | 46.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 290 | 361 | $60,648 | $27,361 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 221 | $34,255 | $19,328 | 56.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 115 | 136 | $47,192 | $16,806 | 35.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 690 | 3,017 | $141,799 | $14,884 | 10.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 302 | 339 | $26,103 | $13,475 | 51.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 50 | 51 | $21,675 | $10,762 | 49.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 57 | 75 | $41,850 | $8,546 | 20.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 163 | 207 | $21,611 | $8,165 | 37.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 88 | 89 | $21,623 | $7,687 | 35.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 21 | 22 | $14,960 | $7,494 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $14,175 | $6,836 | 48.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 34 | 39 | $17,082 | $5,949 | 34.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 42 | 45 | $17,460 | $5,689 | 32.6% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 33 | 35 | $13,160 | $4,313 | 32.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 38 | 39 | $10,686 | $4,057 | 38.0% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 19 | 19 | $6,897 | $3,975 | 57.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 42 | 45 | $7,830 | $3,937 | 50.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 76 | 76 | $8,360 | $3,920 | 46.9% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 24 | 24 | $6,288 | $2,847 | 45.3% |
| 69100 | Biopsy of ear | Office | 2023 | 48 | 52 | $8,164 | $2,790 | 34.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 22 | 22 | $14,388 | $2,478 | 17.2% |
About Dr. Keith Robinson, D.O
Dr. Keith Robinson, D.O is a Dermatology healthcare provider based in Danville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174704183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Robinson, D.O has received a total of $142,628 in payments from pharmaceutical and medical device companies, with $21,488 received in 2024. These payments were reported across 1,640 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($91,118).
As a Medicare-enrolled provider, Robinson has provided services to 20,906 Medicare beneficiaries, totaling 31,609 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine, Dermatology
- Location Danville, VA
- Active Since 11/19/2007
- Last Updated 01/11/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1174704183
Products in Payments
- TALTZ (Drug) $34,837
- SKYRIZI (Biological) $17,639
- VTAMA (Drug) $13,002
- EUCRISA (Drug) $12,980
- CIBINQO (Drug) $10,453
- RINVOQ (Biological) $10,167
- COSENTYX (Biological) $5,403
- SILIQ (Drug) $3,287
- DUPIXENT (Biological) $2,635
- ADBRY (Biological) $2,195
- Humira (Biological) $2,043
- TREMFYA (Drug) $2,018
- HUMIRA (Biological) $1,230
- Sotyktu (Drug) $1,097
- ILUMYA (Biological) $881.58
- Otezla (Drug) $866.46
- COSENTYX (Drug) $739.22
- OPZELURA (Drug) $628.68
- Cimzia (Drug) $615.59
- Enbrel (Biological) $520.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Danville
Carlos Sandoval Madrigal, Fnp, FNP
Dermatology — Payments: $79,608
Dermatology $79,608
Dr. Misha Mutizwa, M.d, M.D
Dermatology — Payments: $56,048
Dermatology $56,048
Jerome Potozkin, Md, MD
Dermatology — Payments: $11,559
Dermatology $11,559
Dr. Katherine Marks, D.o, D.O
Dermatology — Payments: $4,167
Dermatology $4,167
Mikael Horissian
Dermatology — Payments: $3,648
Dermatology $3,648
Jaclyn Tracy
Dermatology — Payments: $3,459
Dermatology $3,459